| 2023 | 2020 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,1 Md € | +0.7% | 1,1 Md € | +113.0% | 516,6 M € | +1.7% | 508,0 M € | |
| EBITDA | 3,5 M € | +45.2% | 2,4 M € | +129.7% | -8,0 M € | -5578.7% | -141,4 k € | |
| Operating profit | -2,1 M € | -72.4% | -1,2 M € | +86.9% | -9,4 M € | -791.1% | -1,1 M € | |
| Profit/loss | -2,7 M € | -449.5% | 765,2 k € | +108.8% | -8,7 M € | -2168.2% | -382,1 k € | |
| Equity | 18,8 M € | -43.5% | 33,3 M € | +40908.5% | 81,2 k € | -99.1% | 8,7 M € | |
| Total assets | 220,9 M € | -15.1% | 260,2 M € | +119.6% | 118,5 M € | +3.2% | 114,8 M € | |
| Cash | 217,9 k € | -48.8% | 425,8 k € | -62.0% | 1,1 M € | +265.5% | 307,0 k € | |
| Debts | 197,4 M € | -10.3% | 220,1 M € | +102.6% | 108,6 M € | +3.9% | 104,5 M € | |
| Staff | 560,1 | 614,7 | 333 | 341,5 | ||||
Public limited company · Woluwe-Saint-Lambert · incorporated on 28/12/1983 · 560,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-48.8%).
Solid counterparty for a standard engagement.
PHOENIX Pharma Belgium is a Public limited company incorporated in 1983. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Woluwe-Saint-Lambert. It employs on average 560,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette